1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Earnings

Abbott Concludes Former Employees’ Allegations Concerning Michigan Formula Plant ‘Unfounded’

Firm Plans Spending $500M To Build US Facility To Boost Formula Production

 
• By Malcolm Spicer

Abbott’s Q3 worldwide sales of formula and other pediatric nutritionals were down 24.8% on reported basis. It plans spending $500m on a new formula facility after finding the US “would benefit from more manufacturing capacity and redundancy.”

• Source: Shutterstock

Abbott is done investigating a former employee’s allegations about quality-control problems at its Michigan infant formula plant but impacts on revenues from temporarily shutting down the facility aren’t done with the firm.

Another impact from the shutdown and Abbott’s related recall of three of its major formula brands the firm announced with...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

BioGaia Takes Probiotics To Netherlands For First Time

 
• By Tom Gallen

Adopting an online approach, BioGaia is set to enter the Dutch market for probiotic dietary supplements. The firm announced the move as it reported lower sales in Q1.

IQVIA Consumer Health: Digestive Category Driving Global OTC Market Growth

 
• By David Ridley

An increasing awareness of and interest in gut health helped the global OTC market grow by 4.6% in value terms in 2024, according to IQVIA Consumer Health.

Dermapharm Seeks To Put Stop To Spanish Slide

 
• By Tom Gallen

Dermapharm shakes up management of Arkopharma subsidiary in Spain with turnaround plan not showing results.

C&D Divesting Flawless, Spinbrush Lines, Says Gummy Vitamin Brands Might Not Stick

 
• By Malcolm Spicer

C&D reports Q1 net sales dropped 2.4% to $1.48bn, below its guidance for around 1% growth. Its brands’ sales at retail and market share grew in the quarter, but “experienced slowing category growth in the US market” as retailers reduced inventory levels.

More from Business

Scope Launches Eyelid-Friendly Eye Cream In The UK

 
• By David Ridley

Eyelids have the "thinnest, most sensitive skin on the body" and are "highly prone to dehydration," which is why Scope has launched new Optase Life Sensitive Eye Daily Renewal Cream.

Get To Know: UK Women’s Wellness Start-Up GP Nutrition

 
• By David Ridley

Meet UK women's health start-up GP Nutrition, run by busy working mother of four Gabriela Peacock, who says she "truly understands the needs of the women who are looking to her for help.”

Portfolios In Large US Food Industry Merger Cleared By FTC Include Nutritional Supplements

 
• By Malcolm Spicer

FTC decision, says Bureau of Competition director Daniel Guarnera, influenced by both companies marketing different lines in different countries, limiting the number of similar products in the same categories the combined firm would offer.